Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126646
Status:
COMPLETED
Last Update Posted:
2010-06-22
First Post:
2005-08-02
Brief Title:
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia Prolymphocytic Leukemia or Non-Hodgkins Lymphoma
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
CDR0000438672
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Robert Kreitman MD
Old Organization:
NCI